过去一年中添加的文章,按日期排序

Aspiration Pneumonitis Caused by Gargling with 10%(w/v) Benzalkonium Chloride Proven by Mixing with an Anionic Surfactant

Y Kurahara, K Tsuyuguchi - Respiratory Endoscopy, 2023 - jstage.jst.go.jp
225 天前 - … of aspiration pneumonitispneumonitis are crucial. Physicians should pay close
attention when diagnosing respiratory symptoms after gargling, especially during the COVID-19

Fixed duration mosunetuzumab plus polatuzumab vedotin has promising efficacy and a manageable safety profile in patients with BTKi relapsed/refractory mantle cell …

ML Wang, S Assouline, M Kamdar, N Ghosh, S Naik… - Blood, 2023 - Elsevier
225 天前 - … Two (10%) Grade (Gr) 5 AEs occurred, both of which were due to COVID-19
pneumonia… pt with Gr 3 pneumonitis (related to M-Pola); and 2 pts with Gr 5 COVID-19 pneumonia …

Pembrolizumab (pembro) in Children and Young Adults with High-Risk Classical Hodgkin Lymphoma (cHL) with Slow Early Response (SER) to Front-Line …

C Mauz-Koerholz, A Beishuizen, L Vinti, A Ceraulo… - Blood, 2023 - Elsevier
225 天前 - Background: cHL is one of the most curable forms of childhood cancer, but patients
(pts) who have a SER to initial chemo are at high risk of relapse. The approaches currently …

A Phase 2 Study of Acalabrutinib, Umbralisib, and Ublituximab (AU2) in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

IE Ahn, Y Zhou, S Tyekucheva, H Cormier… - Blood, 2023 - Elsevier
225 天前 - … In addition, 7 (24%) patients stopped umbralisib between C15-19 due to
discontinuation of drug supply; these patients remained on acalabrutinib monotherapy until C24. All …

Acalabrutinib in Chinese Patients (Pts) with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): 12-Month Efficacy and Safety Results from an Open …

S Yang, H Huang, K Zhou, X Zhao, Y Han, L Li… - Blood, 2023 - Elsevier
225 天前 - … AEs leading to dose interruption were reported in 13 pts (21.7%), most commonly
COVID-19 (5.0%), neutrophil count decreased (3.3%), and platelet count decreased (3.3%). …

Small-Dose Trimethoprim-Sulfamethoxazole Prevents Pneumocystis Jiroveci Pneumonia in B-Cell Lymphoma Patients Receiving Chemotherapy: Analysis of a …

C Liu, X Zhang, Y Zhu, F Xiao, Y Lv, X Ye, X Li, J Wei… - Blood, 2023 - Elsevier
225 天前 - … prevention of interstitial pneumonitis was conducted at … COVID-19, in addition to
no patients developing IP. Forty (47.1%) in the control group developed IP, 16 were COVID-19, …

Martin's Story Post COVID-19: A Journey of Recovery

P Copeland - Clinical Practice and Post-Infection Care for COVID-19 …, 2024 - igi-global.com
226 天前 - … Martin’s story post COVID-19, written in his own words, … fibrillation underpinned
by COVID-19 pneumonitis to the … and psychological impact that COVID-19 had on Martin and …

Development of mRNA nano-vaccines for COVID-19 prevention and its biochemical interactions with various disease conditions and age groups

MMFA Baig, LY Wong, H Wu - Journal of Drug Targeting, 2024 - Taylor & Francis
226 天前 - … anti-COVID-19 vaccine-induced pneumonitis could happen … that the development
of pneumonitis occurred due to Type … Which established that the anti-COVID-19 mRNA nano-…

Vedolizumab-induced organizing pneumonia in a patient with ulcerative colitis: a case report

장영인, 김동현, 오신주, 이창균 - 대한내과학회추계학술발표논문집, 2023 - kaim.or.kr
233 天前 - … Antibiotics treatment showed no improvement clinically, so we suspected drug-induced
pneumonitis by the recently started vedolizumab. In laboratory tests, the COVID-19 test …

Clinicians with long covid must get financial support, say unions

A Rimmer - 2023 - bmj.com
236 天前 - … include persisting pneumonitis or lung fibrosis after acute covid-19 pneumonitis
and … of covid-19. Ischaemic stroke and myocardial infarction developing within 28 days of a …